New injection relieves symptoms of Crohn's disease
UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.
Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
